Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial.
David A PalmaRobert OlsonStephen HarrowRohann J M CorreaFamke SchneidersCornelis J A HaasbeekGeorge B RodriguesMichael LockBrian P YaremkoGlenn S BaumanBelal AhmadDevin SchellenbergMitchell LiuStewart GaedeJoanna LabaLiam MulroySashendra SenthiAlexander V LouieAnand SwaminathAnthony ChalmersAndrew WarnerBen J SlotmanTanja D de GruijlAlison AllanSuresh SenanPublished in: BMC cancer (2019)
Clinicaltrials.gov identifier: NCT03721341 . Date of registration: October 26, 2018.